BSX vs. DGX: Boston Scientific vs. Quest Diagnostics Stock Comparison
How do Boston Scientific (BSX) and Quest Diagnostics (DGX) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Boston Scientific (BSX) and Quest Diagnostics (DGX) both fall under the Health Care Equipment & Services industry group, but BSX is classified in Health Care Equipment & Supplies while DGX is classified in Health Care Providers & Services.
| Profile Item | BSX | DGX |
|---|---|---|
| Name | Boston Scientific Corp. | Quest Diagnostics Incorporated |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Services |
| Market Capitalization | 61.96 billion USD | 28.21 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | May 19, 1992 | December 17, 1996 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BSX | DGX |
|---|---|---|
| Total Return (1Y) | -55.98% | 45.88% |
| Total Return (3Y, Annualized) | -5.05% | 27.45% |
| Total Return (5Y, Annualized) | 0.57% | 14.84% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BSX | DGX |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 24.06% |
| Beta (5Y) | 0.57 | 0.54 |
| Max Drawdown (5Y) | -61.55% | -28.62% |
| Avg. Volume (3M) | 19.73M | 1.00M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BSX | DGX |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | 1.73 |
| Sortino Ratio (1Y) | -1.80 | 3.16 |
Profitability
ROE (TTM)
Quest Diagnostics (DGX) at 15.32% sits in the top ROE quartile, while Boston Scientific (BSX) at 14.12% is closer to the peer norm — stronger capital efficiency for DGX.
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
DGX
Health Care Equipment & Services industry group
15.32%
- Max
- 47.61%
- DGX
- 15.32%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Boston Scientific (BSX) at 16.62% and Quest Diagnostics (DGX) at 9.54% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
DGX
Health Care Equipment & Services industry group
9.54%
- Max
- 29.35%
- DGX
- 9.54%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Boston Scientific (BSX) at 19.05% and Quest Diagnostics (DGX) at 15.63% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
DGX
Health Care Equipment & Services industry group
15.63%
- Max
- 35.43%
- DGX
- 15.63%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BSX | DGX |
|---|---|---|
| ROE (TTM) | 14.12% | 15.32% |
| ROA (TTM) | 5.87% | 6.61% |
| Net Margin (TTM) | 16.62% | 9.54% |
| Operating Margin (TTM) | 19.05% | 15.63% |
| Gross Margin (TTM) | 67.98% | 33.18% |
Growth
Revenue Growth
Both Boston Scientific (BSX) at 19.87% and Quest Diagnostics (DGX) at 11.78% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Boston Scientific (BSX) at 55.20% sits in the top EPS growth quartile, while Quest Diagnostics (DGX) at 13.78% is closer to the peer norm — faster per-share earnings growth for BSX.
Growth Metrics
| Metric | BSX | DGX |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | 11.78% |
| Revenue Growth (3Y CAGR) | 16.54% | 3.74% |
| EPS Growth (YoY) | 55.20% | 13.78% |
| EPS Growth (3Y CAGR) | 62.75% | 3.16% |
Financial Strength
Current Ratio (MRQ)
Quest Diagnostics (DGX) at 1.70 keeps current ratio within its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for BSX.
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
DGX
Health Care Equipment & Services industry group
1.70
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DGX
- 1.70
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Boston Scientific (BSX) at 0.46 and Quest Diagnostics (DGX) at 0.80 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
DGX
Health Care Equipment & Services industry group
0.80
- Max
- 1.88
- Q3
- 0.91
- DGX
- 0.80
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BSX | DGX |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 1.70 |
| Debt / Equity (MRQ) | 0.46 | 0.80 |
| Net Debt / EBITDA | 2.04 | 2.38 |
Dividends
Dividend Yield (TTM)
Boston Scientific (BSX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a yield of 1.33%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DGX
Health Care Equipment & Services industry group
1.33%
- DGX
- 1.33%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Boston Scientific (BSX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a payout of 25.10%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DGX
Health Care Equipment & Services industry group
25.10%
- DGX
- 25.10%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BSX | DGX |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 1.33% |
| Dividend Payout Ratio (TTM) | 0.00% | 25.10% |
Valuation
P/E Ratio (TTM)
Boston Scientific (BSX) at 18.04 sits in the cheaper P/E ratio quartile, while Quest Diagnostics (DGX) at 25.46 is closer to its industry’s usual earnings multiple — a discount for BSX, though growth and earnings durability still matter.
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
DGX
Health Care Equipment & Services industry group
25.46
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- DGX
- 25.46
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Boston Scientific (BSX) at 2.94 and Quest Diagnostics (DGX) at 2.38 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
DGX
Health Care Equipment & Services industry group
2.38
- Max
- 8.80
- Q3
- 4.32
- DGX
- 2.38
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Boston Scientific (BSX) at 2.42 and Quest Diagnostics (DGX) at 3.68 are valued close to their industries’ norm against book — neither stands out from peers.
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
DGX
Health Care Equipment & Services industry group
3.68
- Max
- 11.68
- Q3
- 6.12
- DGX
- 3.68
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BSX | DGX |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | 25.46 |
| P/S Ratio (TTM) | 2.94 | 2.38 |
| P/B Ratio (MRQ) | 2.42 | 3.68 |
| Free Cash Flow Yield (TTM) | 4.02% | 3.09% |